July 1st, 2019

Dr. Stefano Biondi Appointed Head of CMC of BioVersys

BioVersys is strengthening its executive management team with the appointment of Dr. Stefano Biondi...

June 20th, 2019

BioVersys announces a EUR 6.92 Million funding of its TRIC-TB project by the IMI2 JU

BioVersys is pleased to announce that it has received an IMI2 JU grant of 6.92 million EUR to fund...

May 25th, 2019

BioVersys Receives QIDP Designation from the U.S. FDA for the Development of BV100

BioVersys to develop BV100 in critical care indications

BioVersys AG a privately owned, multi-asset...

May 24th, 2019

BioVersys to participate in the Global AMR Challenge

BioVersys is proud to participate in the #Globalamrchallenge. Find out more on the CDC website.